Concentration of Mitoquinone Mesylate in Skeletal Muscle After a Single Oral Dose of MitoQ
试验速览
- 阶段
- 不适用
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Muscle mitoquinone mesylate concentration
研究概览
简要总结
The purpose of this study is to determine mitoquinone mesylate concentration levels in skeletal muscle samples obtained after intake of an acute oral dose of MitoQ.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •18-40 years of age
排除标准
- •Previous use of MitoQ or CoQ-10 within 30 days of screening appointment
- •Ongoing use of MitoQ
- •Ongoing treatment with medications
- •Disease deemed by the MD to infer a risk to participate in the trial
研究组 & 干预措施
MitoQ
Subjects ingest 160 mg of MitoQ
干预措施: MitoQ (Dietary Supplement)
结局指标
主要结局
Muscle mitoquinone mesylate concentration
时间窗: 5 hours after oral administration of MitoQ
Concentration of mitoquinone mesylate in skeletal muscle
Muscle mitoquinone mesylate concentration
时间窗: Before oral administration of MitoQ
Concentration of mitoquinone mesylate in skeletal muscle
Muscle mitoquinone mesylate concentration
时间窗: 1 hours after oral administration of MitoQ
Concentration of mitoquinone mesylate in skeletal muscle
Muscle mitoquinone mesylate concentration
时间窗: 3 hours after oral administration of MitoQ
Concentration of mitoquinone mesylate in skeletal muscle
次要结局
- Blood mitoquinone mesylate concentration(Before as well as 0.5, 1, 1.5, 2, 3, 4 and 5 hours after oral administration of MitoQ)
研究者
Morten Hostrup, PhD
Associate Professor
University of Copenhagen